cetuximab for oropharyngeal cancer: latest data from de-escalate
Published 5 years ago • 440 plays • Length 4:57Download video MP4
Download video MP3
Similar videos
-
1:23
evaluating options for hpv oropharyngeal cancer: cisplatin-rt vs. cetuximab-rt
-
3:58
updates on hpv oropharyngeal cancer - de-escalation and reducing costs with cisplatin
-
5:52
cisplatin superior to cetuximab for hpv oropharyngeal cancer
-
4:58
cisplatin v cetuximab for hpv associated oropharyngeal cancer
-
3:28
head and neck cancer challenges & cetuximab trial updates
-
3:26
results from trial of de-escalated adjuvant radiation therapy for hpv-associated oropharynx cancer
-
1:21
response-adaptive treatment de-escalation in patients with hpv oropharyngeal cancer
-
4:00
incorporating cetuximab in head and neck cancer treatment
-
8:10
de-escalating chemo-radiotherapy in locally advanced hpv oropharynx cancer
-
10:26
cetuximab or chemotherapy in hnscc?
-
1:37
treatment de-escalation in head and neck cancer
-
2:20
prognostic factors and surgery in hpv-related oropharyngeal cancer
-
8:19
cetuximab use for hnscc
-
4:55
lba9_pr - cetuximab versus cisplatin in hpv-positive, low risk oropharyngeal cancer, receiving r...
-
44:26
are we ready to de-escalate? treatment of hpv head and neck cancer
-
1:13
radiation and adjuvant nivolumab in hpv oropharynx cancer
-
1:21
reach safety data: avelumab plus rt-cetuximab in la scchn
-
1:24
fire-4.5: folfoxiri plus either bevacizumab or cetuximab as 1l treatment of braf v600e-mutant mcrc
-
4:25
fire-4.5: folfoxiri plus either bevacizumab or cetuximab in mcrc